{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:29:23Z","timestamp":1787156963307,"version":"build-2736575974"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction characterized by recurrent abdominal pain and altered bowel habits, resulting in a substantial impact on quality of life. Owing to the multifactorial nature of IBS and the limitations of current treatment options, Traditional Chinese Medicine (TCM) has increasingly been investigated as a complementary therapeutic approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This narrative review examines the pathogenesis of IBS from the perspective of TCM, with particular emphasis on the interrelationships among the heart, liver, and spleen within the framework of interpromotion and interrestraint theory. It also summarizes representative TCM-based intervention strategies and discusses their potential conceptual links to contemporary biomedical mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A narrative review approach was adopted. Relevant literature concerning IBS pathogenesis, TCM theories, and TCM-based interventions was identified through searches of major scientific databases. Findings from experimental and clinical studies were synthesized qualitatively to provide an overview of current evidence and research trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Current evidence suggests that TCM interventions may influence multiple biological processes implicated in IBS, including brain-gut axis signaling, gastrointestinal motility, gut microbiota composition, intestinal barrier function, immune regulation, and visceral sensitivity. Emerging studies also suggest potential conceptual associations between traditional TCM concepts and modern pathophysiological mechanisms; however, these relationships remain hypothesis-generating and require further experimental validation. However, interpretation of the evidence is limited by heterogeneity in study design, syndrome differentiation, intervention protocols, and outcome assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TCM provides a complementary framework for understanding and managing IBS and may offer therapeutic benefits through multidimensional regulatory effects. Nevertheless, the overall quality of available evidence remains variable, and many mechanistic findings are derived primarily from preclinical studies. Further high-quality clinical research, standardized outcome measures, and biomarker-based investigations are needed to clarify the clinical value and biological basis of TCM interventions in IBS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1823683","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:58:33Z","timestamp":1787155113000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathogenesis and therapeutic strategies for irritable bowel syndrome: an integrated perspective from dynamic balance theory of Chinese medicine"],"prefix":"10.3389","volume":"13","author":[{"given":"Nanxi","family":"Liu","sequence":"first","affiliation":[{"name":"The First School of Clinical Medicine, Shaanxi University of Traditional Chinese Medicine","place":["Xianyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Huang","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Shaanxi University of Traditional Chinese Medicine","place":["Xianyang, China"]},{"name":"Xi'an Hospital of Traditional Chinese Medicine","place":["Xi'an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[{"name":"Xi'an Hospital of Traditional Chinese Medicine","place":["Xi'an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixia","family":"Qiao","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Shaanxi University of Traditional Chinese Medicine","place":["Xianyang, China"]},{"name":"Xi'an Hospital of Traditional Chinese Medicine","place":["Xi'an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/nrdp.2016.14","article-title":"Irritable bowel syndrome","volume":"2","author":"Enck","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/S0140-6736(20)31548-8","article-title":"Irritable bowel syndrome","volume":"396","author":"Ford","year":"2020","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"683191","DOI":"10.3389\/fnut.2021.683191","article-title":"A low-FODMAP diet improves the global symptoms and bowel habits of adult IBS patients: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2021","journal-title":"Front Nutr"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/j.1365-2982.2008.01143.x","article-title":"A population-based study of irritable bowel syndrome in a non-Western population","volume":"20","author":"Husain","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.3748\/wjg.v29.i26.4120","article-title":"Irritable bowel syndrome: epidemiology, overlap disorders, pathophysiology and treatment","volume":"29","author":"Huang","year":"2023","journal-title":"World J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/apt.17132","article-title":"Impact of Rome IV irritable bowel syndrome on work and activities of daily living","volume":"56","author":"Goodoory","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/MED.000000000000018","article-title":"Targeted pharmacotherapy of irritable bowel syndrome","volume":"28","author":"Arokiadoss","year":"2021","journal-title":"Curr Opin Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S2468-1253(20)30212-0","article-title":"The overlap between irritable bowel syndrome and organic gastrointestinal diseases","volume":"6","author":"Aziz","year":"2021","journal-title":"Lancet Gastroenterol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e0192319","DOI":"10.1371\/journal.pone.0192319","article-title":"Efficacy and safety of modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management: a meta-analysis of randomized, positive medicine-controlled trials","volume":"13","author":"Dai","year":"2018","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1053\/j.gastro.2016.02.032","article-title":"Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3390\/nu13051506","article-title":"Diarrhea predominant-irritable bowel syndrome (IBS-D): effects of different nutritional patterns on intestinal dysbiosis and symptoms","volume":"13","author":"Altomare","year":"2021","journal-title":"Nutrients"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41575-020-0286-8","article-title":"Global burden of irritable bowel syndrome: trends, predictions and risk factors","volume":"17","author":"Black","year":"2020","journal-title":"Nat Rev Gastro Hepat"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S2468-1253(19)30324-3","article-title":"Efficacy of soluble fibre, antispasmodic drugs, and gut\u2013brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis","volume":"5","author":"Black","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41575-025-01065-9","article-title":"Common misconceptions and controversies in the management of irritable bowel syndrome","volume":"22","author":"Black","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/gutjnl-2022-328515","article-title":"Irritable bowel syndrome: treatment based on pathophysiology and biomarkers","volume":"72","author":"Camilleri","year":"2023","journal-title":"Gut"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"424646","DOI":"10.3389\/fmicb.2019.01136","article-title":"The microbiome and irritable bowel syndrome\u2013a review on the pathophysiology, current research and future therapy","volume":"10","author":"Chong","year":"2019","journal-title":"Front Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/apt.15325","article-title":"Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome","volume":"50","author":"Zamani","year":"2019","journal-title":"Aliment Pharm Ther"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.gtc.2018.07.002","article-title":"Brain-gut axis clinical implications","volume":"47","author":"Khlevner","year":"2018","journal-title":"Gastroenterol Clin N"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41579-024-01136-9","article-title":"Microbiota-neuroepithelial signalling across the gut-brain axis","volume":"23","author":"Ohara","year":"2025","journal-title":"Nat Rev Microbiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","article-title":"Nociplastic pain: towards an understanding of prevalent pain conditions","volume":"397","author":"Fitzcharles","year":"2021","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-023-05829-8","article-title":"Gut enterochromaffin cells drive visceral pain and anxiety","volume":"616","author":"Bayrer","year":"2023","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4939-0897-49","article-title":"Neuropeptides and the microbiota-gut-brain axis","volume":"817","author":"Holzer","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.chom.2015.12.005","article-title":"The host shapes the gut microbiota via fecal microRNA","volume":"19","author":"Liu","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.3390\/nu13062112","article-title":"Probiotics, prebiotics, and synbiotics: implications and beneficial effects against irritable bowel syndrome","volume":"13","author":"Simon","year":"2021","journal-title":"Nutrients"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s11682-019-00087-7","article-title":"Changes of the postcentral cortex in irritable bowel syndrome patients","volume":"14","author":"Nan","year":"2020","journal-title":"Brain Imaging Behav"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.3748\/wjg.v22.i28.6402","article-title":"Personality traits and emotional patterns in irritable bowel syndrome","volume":"22","author":"Muscatello","year":"2016","journal-title":"World J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S2468-1253(16)30022-X","article-title":"Functional gastrointestinal disorders: what\u2019s new for Rome IV?","volume":"1","author":"Drossman","year":"2016","journal-title":"Lancet Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5009\/gnl18296","article-title":"Depression promotes the onset of irritable bowel syndrome through unique dysbiosis in rats","volume":"13","author":"Takajo","year":"2019","journal-title":"Gut Liver"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12866-024-03592-y","article-title":"FMT and TCM to treat diarrhoeal irritable bowel syndrome with induced spleen deficiency syndrome-microbiomic and metabolomic insights","volume":"24","author":"Tang","year":"2024","journal-title":"BMC Microbiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cgh.2008.02.060","article-title":"Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome","volume":"6","author":"Camilleri","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jad.2020.01.124","article-title":"Feeling down? A systematic review of the gut microbiota in anxiety\/depression and irritable bowel syndrome","volume":"266","author":"Simpson","year":"2020","journal-title":"J Affect Disord"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1016\/j.cgh.2020.08.043","article-title":"The role of resilience in irritable bowel syndrome, other chronic gastrointestinal conditions, and the general population","volume":"19","author":"Parker","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/PSY.0000000000000729","article-title":"Insula activity to visceral stimulation and endocrine stress responses as associated with alexithymia in patients with irritable bowel syndrome","volume":"82","author":"Kano","year":"2020","journal-title":"Psychosom Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.12.023","article-title":"The brain-gut-microbiotal axis: a framework for understanding functional GI illness and their therapeutic interventions","volume":"84","author":"Tait","year":"2021","journal-title":"Eur J Intern Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fpubh.2017.00258","article-title":"An overview of heart rate variability metrics and norms","volume":"5","author":"Shaffer","year":"2017","journal-title":"Front Public Health"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.5056\/jnm17017","article-title":"Effects of cognitive behavior therapy on heart rate variability in young females with constipation-predominant irritable bowel syndrome: a parallel-group trial","volume":"23","author":"Jang","year":"2017","journal-title":"J Neurogastroenterol Motil"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"G775","DOI":"10.1152\/ajpgi.00155.2012","article-title":"Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome","volume":"303","author":"Camilleri","year":"2012","journal-title":"Am J Physiol-Gastr L"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1756284821993586","DOI":"10.1177\/1756284821993586","article-title":"Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review","volume":"14","author":"Hanning","year":"2021","journal-title":"Ther Adv Gastroenterol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"10598","DOI":"10.3390\/ijms262110598","article-title":"Unraveling the pathophysiology of irritable bowel syndrome: mechanisms and insights","volume":"26","author":"Aggeletopoulou","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40168-022-01450-5","article-title":"Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes","volume":"11","author":"Jacobs","year":"2023","journal-title":"Microbiome"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1142\/S0192415X24500629","article-title":"Bridging the gap: a comprehensive study on traditional Chinese medicine strategies for managing adult irritable bowel syndrome","volume":"52","author":"Wei","year":"2024","journal-title":"Am J Chin Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.14309\/ajg.0000000000002500","article-title":"Global prevalence of psychological distress and comorbidity with disorders of gut-brain interactions","volume":"119","author":"Trindade","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/ajg.2008.122","article-title":"An evidence-based position statement on the management of irritable bowel syndrome","volume":"104","author":"Brandt","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.13288\/j.11-2166\/r.2021.13.003","article-title":"Professor Yang Chunbo\u2019s experience in treating chronic constipation","volume":"62","author":"He","year":"2021","journal-title":"J Tradit Chin Med"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S2468-1253(19)30089-5","article-title":"The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment","volume":"4","author":"Gracie","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41575-024-01033-9","article-title":"Rome foundation working team report on overlap in disorders of gut-brain interaction","volume":"22","author":"Barbara","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1136\/gutjnl-2020-322519","article-title":"Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care","volume":"70","author":"Black","year":"2021","journal-title":"Gut"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.3748\/wjg.v26.i40.6141","article-title":"Role of gut microbiota via the gut-liver-brain axis in digestive diseases","volume":"26","author":"Ding","year":"2020","journal-title":"World J Gastroenterol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00535-020-01746-z","article-title":"Evidence-based clinical practice guidelines for irritable bowel syndrome 2020","volume":"56","author":"Fukudo","year":"2021","journal-title":"J Gastroenterol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1136\/gutjnl-2021-324598","article-title":"British Society of Gastroenterology guidelines on the management of irritable bowel syndrome","volume":"70","author":"Vasant","year":"2021","journal-title":"Gut"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e01772","DOI":"10.1002\/cbdv.202501772","article-title":"Unveiling the mechanism underlying Diyu Shengbai tablet in remediating leukopenia based on network pharmacology, metabonomics, and fecal transcriptomics","volume":"23","author":"Wang","year":"2026","journal-title":"Chem Biodivers"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3390\/molecules27051680","article-title":"The role of serotonin neurotransmission in gastrointestinal tract and pharmacotherapy","volume":"27","author":"Guzel","year":"2022","journal-title":"Molecules"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.13412\/j.cnki.zyyl.2017.06.025","article-title":"A mechanism exploration of alcohol extracts of Psoralea corylifolia L and nutmeg treating the irritable bowel syndrome visceral hypersensitivity rats based on CRF-CREB signaling pathway","volume":"33","author":"Wei","year":"2017","journal-title":"Pharmacol Clin Chin Mater Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1053\/j.gastro.2022.04.017","article-title":"Actice guideline on the pharmacological management of irritable bowel syndrome with diarrhea","volume":"163","year":"2022","journal-title":"Gastroenterology"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5152\/tjg.2020.20229","article-title":"Inflammation in irritable bowel syndrome (IBS): role of psyllium fiber supplementation in decreasing inflammation and physiological management of IBS","volume":"32","author":"Garg","year":"2021","journal-title":"Turk J Gastroenterol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"709","DOI":"10.20452\/pamw.16067","article-title":"Recent advances in the treatment of irritable bowel syndrome","volume":"131","author":"Bonetto","year":"2021","journal-title":"Pol Arch Intern Med"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"b3154","DOI":"10.1136\/bmj.b3154","article-title":"Soluble or insoluble fibre in irritable bowel syndrome in primary care?","volume":"339","author":"Bijkerk","year":"2009","journal-title":"Randomised placebo controlled trial. BMJ"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3390\/nu15071647","article-title":"Constipation-predominant irritable bowel syndrome (IBS-C): effects of different nutritional patterns on intestinal dysbiosis and symptoms","volume":"15","author":"Di Rosa","year":"2023","journal-title":"Nutrients"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1007\/s00394-020-02473-0","article-title":"Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis","volume":"60","author":"van Lanen","year":"2021","journal-title":"Eur J Nutr"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1136\/gutjnl-2015-311339","article-title":"FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial","volume":"66","author":"McIntosh","year":"2017","journal-title":"Gut"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"947","DOI":"10.14309\/ajg.0000000000001767","article-title":"The role of food in the treatment of bowel disorders: focus on irritable bowel syndrome and functional constipation","volume":"117","author":"Singh","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/jama.2020.22532","article-title":"Diagnosis and treatment of irritable bowel syndrome: a review","volume":"325","author":"Camilleri","year":"2021","journal-title":"JAMA"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.gastro.2019.08.026","article-title":"Efficacy and safety of peppermint oil in a randomized, double-blind trial of patients with irritable bowel syndrome","volume":"158","author":"Weerts","year":"2020","journal-title":"Gastroenterology"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41575-023-00794-z","article-title":"Irritable bowel syndrome and mental health comorbidity-approach to multidisciplinary management","volume":"20","author":"Staudacher","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S2468-1253(19)30226-2","article-title":"Faecal microbiota transplantation for IBS: still a long way to go","volume":"4","author":"Moayyedi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"609","DOI":"10.7326\/M16-0271","article-title":"Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial","volume":"165","author":"Kelly","year":"2016","journal-title":"Ann Intern Med"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"CD004116","DOI":"10.1002\/14651858.CD004116.pub2","article-title":"Herbal medicines for treatment of irritable bowel syndrome","volume":"1","author":"Liu","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"940328","DOI":"10.3389\/fmed.2022.940328","article-title":"External therapy of traditional Chinese medicine for treating irritable bowel syndrome with diarrhea: a systematic review and meta-analysis","volume":"9","author":"Wei","year":"2022","journal-title":"Front Med"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"e37982","DOI":"10.1097\/MD.0000000000037982","article-title":"Different acupuncture and moxibustion therapies in the treatment of IBS-D with anxiety and depression: a network meta-analysis","volume":"103","author":"Hou","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"e2248817","DOI":"10.1001\/jamanetworkopen.2022.48817","article-title":"Acupuncture for the treatment of diarrhea-predominant irritable bowel syndrome: a pilot randomized clinical trial","volume":"5","author":"Qi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s0163-7258(00)00039-5","article-title":"Traditional Chinese medicine: an approach to scientific proof and clinical validation","volume":"86","author":"Yuan","year":"2000","journal-title":"Pharmacol Ther"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"336468","DOI":"10.3389\/fnins.2018.00049","article-title":"The vagus nerve at the interface of the microbiota-gut-brain axis","volume":"12","author":"Bonaz","year":"2018","journal-title":"Front Neurosci"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.3346\/jkms.2026.41.e78","article-title":"Role of gut microbiota in psychiatric disorders: from mechanistic insights to therapeutic strategies","volume":"41","author":"Kim","year":"2026","journal-title":"J Korean Med Sci"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"121308","DOI":"10.1016\/j.jep.2026.121308","article-title":"Tianwangbuxiandan decoction alleviates constipation and associated emotional disorders via regulating the brain-gut axis: involving MAPK\/ERK\/JNK signaling pathways","volume":"362","author":"Li","year":"2026","journal-title":"J Ethnopharmacol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.3969\/j.issn.1008-0805.2014.09.061","article-title":"Effect of liver-discharging, qi-regulating and intestines-moistening therapy on gastrointestinal hormone in patients with constipation-predominant irritable bowel syndrome","volume":"25","author":"Xu","year":"2014","journal-title":"LiShiZhen Med Mater Med Res"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"e49997","DOI":"10.7759\/cureus.49997","article-title":"Atractylodes macrocephala-Paeonia lactiflora class formula for the treatment of irritable bowel syndrome: a systematic review with meta-analysis and trial sequential analysis","volume":"15","author":"Bai","year":"2023","journal-title":"Cureus"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s11655-019-3030-x","article-title":"Post-marketing re-evaluation of tongxiening granules in treatment of diarrhea-predominant irritable bowel syndrome: a multi-center, randomized, double-blind, double-dummy and positive control trial","volume":"25","author":"Tang","year":"2019","journal-title":"Chin J Integr Med"},{"key":"ref80","first-page":"33","article-title":"Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications","volume":"60","author":"Larauche","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/7680963","article-title":"Acupuncture plus Chinese herbal medicine for irritable bowel syndrome with diarrhea: a systematic review and meta-analysis","volume":"2019","author":"Yan","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3736\/jcim20091009","article-title":"Tongxie Yaofang inhibits the contraction of colonic smooth muscle isolated from rats through a mechanism related to calcium mobilization","volume":"7","author":"Yuan","year":"2009","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"9086034","DOI":"10.1155\/2017\/9086034","article-title":"The effect of Tong - Xie - Yao - fang on intestinal mucosal mast cells in postinfectious irritable bowel syndrome rats","volume":"2017","author":"Ma","year":"2017","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"152","DOI":"10.13422\/j.cnki.syfjx.2018020152","article-title":"Effect of Tongxie Yaofang with or without Saposhnikoviae radix on colonic visceral hypersensitivity and brain-gut peptide in irritable bowel syndrome rats","volume":"24","author":"Liang","year":"2018","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/acm.2006.12.401","article-title":"Effectiveness of the Chinese herbal formula TongXieYaoFang for irritable bowel syndrome: a systematic review","volume":"12","author":"Bian","year":"2006","journal-title":"J Altern Complement Med"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/1472-6882-13-246","article-title":"The inhibitory effect of tongxieyaofang on rats with post infectious irritable bowel syndrome through regulating colonic par-2 receptor","volume":"13","author":"Hu","year":"2013","journal-title":"BMC Complement Altern Med"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12906-019-2749-4","article-title":"Tong-Xie-Yao-fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-\u03baB and notch signalling pathways","volume":"19","author":"Hou","year":"2019","journal-title":"BMC Complement Altern Med"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"4893876","DOI":"10.1155\/2019\/4893876","article-title":"Clinical effects and safety of Tongxieyaofang on diarrhea predominant irritable bowel syndrome: a meta-analysis of randomized trails","volume":"2019","author":"Zhou","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"6679348","DOI":"10.1155\/2021\/6679348","article-title":"Tongxie Anchang decoction relieves visceral hypersensitivity in diarrhea-predominant irritable bowel syndrome rats by regulating the NGF\/TrkA signaling pathway","volume":"2021","author":"Tan","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3389\/fphar.2018.01110","article-title":"Tong-Xie-Yao-fang regulates 5-HT level in diarrhea predominant irritable bowel syndrome through gut microbiota modulation","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1142\/S0192415X15500019","article-title":"Traditional Chinese medicine formulas for irritable bowel syndrome: from ancient wisdoms to scientific understandings","volume":"43","author":"Xiao","year":"2015","journal-title":"Am J Chin Med"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3748\/wjg.v23.i5.810","article-title":"Gut microbial diversity analysis using Illumina sequencing for functional dyspepsia with liver depression-spleen deficiency syndrome and the interventional Xiaoyaosan in a rat model","volume":"23","author":"Qiu","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"2723705","DOI":"10.1155\/2020\/2723705","article-title":"Network pharmacology identifies the mechanisms of action of Tongxie Anchang decoction in the treatment of irritable bowel syndrome with diarrhea predominant","volume":"2020","author":"Tan","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"904657","DOI":"10.3389\/fphar.2022.904657","article-title":"Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: evidence for clinical practice and future trials","volume":"13","author":"Liang","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3969\/j.issn.1002-2406.2017.06.015","article-title":"Compatibility research on couple medicinal of Baizhu-Baishao in \u201cpurging the wood from the earth\u201d","volume":"34","author":"Yue","year":"2017","journal-title":"Inf Tradit Chin Med"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"e018362","DOI":"10.1136\/bmjopen-2017-018362","article-title":"Effect of herbal extract granules combined with otilonium bromide on irritable bowel syndrome with diarrhoea: a study protocol for a randomised controlled trial","volume":"7","author":"Kim","year":"2017","journal-title":"BMJ Open"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1085\/jgp.201812066","article-title":"Serotonin transport in the 21st century","volume":"151","author":"Rudnick","year":"2019","journal-title":"J Gen Physiol"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1053\/j.gastro.2022.02.016","article-title":"Mucosal serotonin reuptake transporter expression in irritable bowel syndrome is modulated by gut microbiota via mast cellprostaglandin E2","volume":"162","author":"Gao","year":"2022","journal-title":"Gastroenterology"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3969\/j.issn.1003-9783.2012.06.005","article-title":"Influence of fructus Aurantii Immaturus flavonoids on gastrointestinal motility in rats with functional dyspepsia","volume":"23","author":"Huang","year":"2012","journal-title":"Tradit Chin Drug Res Clin Pharmacol"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.13288\/j.11-2166\/r.2015.12.019","article-title":"Effect of Mazhi Jiangzhuo fang on intestinal interstitial cell of rats with constipation type of irritable bowel syndrome","volume":"56","author":"Yang","year":"2015","journal-title":"J Tradit Chin Med"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3969\/j.issn.1008-8849.2014.04.001","article-title":"Effect of Maziren pills on the content of 5-HT in intestinal mucosa in rats with constipation-type irritable bowel syndrome","volume":"23","author":"Lin","year":"2014","journal-title":"Mod J Integr Tradit Chin West Med"},{"key":"ref102","first-page":"12","volume-title":"The Clinical Study of Maren Pills Flavored in Treating Constipation Predominant Irritable Bowel Syndrome of children","author":"Fu","year":"2015"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"111889","DOI":"10.1016\/j.jep.2019.111889","article-title":"The effect of Xiang-sha-Liu-Jun-zi tang (XSLJZT) on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial","volume":"238","author":"Shih","year":"2019","journal-title":"J Ethnopharmacol"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"746923","DOI":"10.3389\/fphar.2021.746923","article-title":"An integrated gut microbiota and network pharmacology study on fuzi-lizhong pill for treating diarrhea-predominant irritable bowel syndrome","volume":"12","author":"Zhen","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"670","DOI":"10.16438\/j.0513-4870.2018-0920","article-title":"Experimental study on the effect of Sishen wan on intestinal flora in rats with diarrhea-type irritable bowel syndrome","volume":"54","author":"Liu","year":"2019","journal-title":"Acta Pharm Sin"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11011-014-9554-z","article-title":"The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling","volume":"30","author":"Yu","year":"2015","journal-title":"Metab Brain Dis"},{"key":"ref107","year":"2015"},{"key":"ref108","first-page":"4494","article-title":"Treatment of diarrhea irritable bowel syndrome with anxiety or depression from the TCM theory of heart, liver and spleen","volume":"36","author":"Wu","year":"2021","journal-title":"China J Tradit Chin Med Pharm"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"894122","DOI":"10.3389\/fphar.2022.894122","article-title":"An overview of systematic reviews of herbal medicine for irritable bowel syndrome","volume":"13","author":"Jun","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"859967","DOI":"10.3389\/fcimb.2022.859967","article-title":"Efficacy of probiotics for irritable bowel syndrome: a systematic review and network meta-analysis","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1053\/j.gastro.2025.05.016","article-title":"Efficacy of ACupuncTure in irritable bOwel syNdrome (ACTION): a multicenter randomized controlled trial","volume":"169","author":"Yang","year":"2025","journal-title":"Gastroenterology"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"1022145","DOI":"10.3389\/fpubh.2022.1022145","article-title":"Clinical evidence of acupuncture and moxibustion for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Yang","year":"2022","journal-title":"Front Public Health"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"47","DOI":"10.13702\/j.1000-0607.20221092","article-title":"Moxibustion ameliorates visceral hypersensitivity by regulating hypothalamus-spinal cordcolon axis in rats with irritable bowel syndrome with diarrhea","volume":"49","author":"Liao","year":"2024","journal-title":"Acupunct Res"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"5105108","DOI":"10.1155\/2016\/5105108","article-title":"Moxibustion for diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"2016","author":"Tang","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"1475366","DOI":"10.3389\/fphar.2024.1475366","article-title":"Herbal placebo response in clinical trials on irritable bowel syndrome: a systematic review and meta-analysis","volume":"15","author":"Huang","year":"2024","journal-title":"Front Pharmacol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1823683\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:58:41Z","timestamp":1787155121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1823683\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":115,"alternative-id":["10.3389\/fmed.2026.1823683"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1823683","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1823683"}}